World Hepatitis Day : Hepatitis and its Treatment

prevention of hepatitis

1. WORLD HEPATITIS DAY 28th July

2. 7/25/2024 2

3. 7/25/2024 3

4. 7/25/2024 4

5. 7/25/2024 5

6. 7/25/2024 6

7. 7/25/2024 7

8. 7/27/2024 8

9. 7/27/2024 9

10. 7/27/2024 10

11. 7/27/2024 11 Hepatitis B: Hepatitis B vaccine was piloted in 2002-03 and then scaled up in entire country in 2010 to protect children from liver diseases such as Jaundice and Cancer. Now it is provided as part of pentavalent vaccine at 6. 10 & 14 weeks apart from birth dose of hepatitis B vaccine.

12. 7/27/2024 12

13. WORLD HEPATITIS DAY 7/25/2024 13

14. 7/25/2024 14

15. 7/27/2024 15

16. 7/27/2024 16

17. 7/27/2024 17

18. 7/27/2024 18

19. 7/27/2024 19

20. 7/27/2024 20

21. 7/27/2024 21

22. 7/27/2024 22 The standard National Guidelines for the Diagnosis and Management of Viral hepatitis by the Technical Resource Group was launched on 28th July 2018 by the NVHCP.

23. 7/27/2024 23

24. 7/27/2024 24

25. 7/27/2024 25

26. 7/27/2024 26

27. 7/27/2024 27

28. 7/27/2024 28

29. 7/27/2024 29

30. 7/25/2024 30 Key Messages: A liver performs over 500 vital functions every single day to keep us alive, that’s why testing, treating and preventing viral hepatitis is so important . Hepatitis is an inflammation of the liver. It’s usually caused by a viral infection or non-infectious agents (such as drugs, toxins, alcohol ). There are 5 main strains of the hepatitis virus, referred to as types A, B, C, D, and E. While they all cause liver disease, they differ in important ways including modes of transmission, severity of illness, geographical distribution, and how they can be prevented. Types B and C hepatitis lead to chronic disease and together are the most common cause of liver cirrhosis, loss of liver function, liver cancer and viral-hepatitis related deaths.

31. 7/25/2024 31 2. Deaths from viral hepatitis-related causes are increasing . Combined , hepatitis B and hepatitis C caused 1.3 million deaths in 2022. Around 304 million people are living with a chronic viral hepatitis infection. 3500 people die from hepatitis B and C infections every day. That’s around one hepatitis death every 30 seconds. Over 6 000 people are newly infected with viral hepatitis each day.

32. 7/25/2024 32 3. Globally, there’s a huge number of undiagnosed and untreated people living with hepatitis . Nearly 220 million with hepatitis B are undiagnosed, while nearly 36 million people with hepatitis C are undiagnosed . Most symptoms only appear once the disease is advanced, with most people discovering they have hepatitis B or C only when they develop serious liver disease or cancer. Even after diagnosis, the coverage of treatment and care for people living with hepatitis is astonishingly low. Of the 304 million people with hepatitis B and C, only 7 million are treated for hepatitis B and 12.5 million cured of hepatitis C.

33. 7/25/2024 33 4. So many hepatitis infections – and deaths – can be prevented . To eliminate hepatitis and achieve the WHO’s ambitious targets by 2030, simplified care services for viral hepatitis should ensure that: all pregnant women living with chronic hepatitis B have access to treatment and their infants have access to hepatitis B birth vaccines to prevent infection; 90 % of people living with hepatitis B and/or hepatitis C are diagnosed; and  80 % of diagnosed people are cured of hepatitis C or treated according to newer hepatitis B expanded eligibility criteria.

34. 7/25/2024 34 It’s time to take action to realize a hepatitis‑free world. Now is the time to prioritize testing, treatment and vaccination to realize a hepatitis-free world and meet our 2030 targets. Key actions include:  expanding access to testing and diagnostics to ensure more people can access the treatment they need;  strengthening primary care prevention efforts to prevent hepatitis through vaccination, safe infection and injections practices and education;  decentralizing hepatitis care to bring care closer to patients by utilizing community-based services;  integrating hepatitis care within existing health services, combining hepatitis treatment with primary care, HIV services, and harm reduction programs where relevant to offer more accessible and comprehensive care;  engaging affected communities and civil society, ensuring that the insights and experiences of people affected by viral hepatitis are at the heart of prevention and treatment efforts; and  mobilizing domestic or innovative financing to secure new funding avenues to support and sustain hepatitis elimination programs.